Loading stock data…
QuidelOrtho Corporation (QDEL)
$13.38-0.59 (-4.22%)
Market ClosedLast close Sep 8
QuidelOrtho Corporation provides diagnostic testing solutions.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
QuidelOrtho Corporation in the Healthcare sector is trading at $13.38 with a market capitalization of $918M. Wall Street consensus targets $14.67 (3 analysts), implying a +9.6% move over the next 12 months. The stock is currently near its 52-week low of $9.92, remaining 31.2% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +9.6% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $619.80M↓ | $723.60M↑ | $699.90M↑ | $613.90M↓ | $692.80M |
| Gross Profit | $263.80M↓ | $320.40M↓ | $335.60M↑ | $274.90M↓ | $343.30M |
| Operating Income | -$27.40M↑ | -$37.30M↓ | $45.20M↑ | -$1.80M↓ | $48.70M |
| Net Income | -$91.80M↑ | -$130.70M↑ | -$733.00M↓ | -$255.40M↓ | -$12.70M |
Peer Comparison
JNJUNHPFE
Fundamentals
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$917.54M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.68
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-59.07%
Volume
Today's trading volume
960,920
Recent News
3 Stocks Under $50 We Think Twice About
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.
1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
3 Unprofitable Stocks with Warning Signs
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
QuidelOrtho (QDEL) Is Up 6.0% After Cutting 2026 Revenue Outlook Amid Narrowing Losses – What's Changed
In early August 2026, QuidelOrtho reported second-quarter 2026 results showing sales of US$630.9 million and a net loss of US$92.9 million, alongside narrower losses per share than a year earlier. However, for the first half of 2026, sales eased to US$1.25 billion and the company reduced its full-year revenue outlook to US$2.52–2.60 billion, highlighting softer expectations despite improving losses. With QuidelOrtho lowering its full-year 2026 revenue guidance, we’ll now examine how this...
QDEL's 2026 Outlook Cut Deepens China and Respiratory Risk Concerns
QuidelOrtho's 2026 outlook cut highlights deeper China and respiratory risks, while cash use and rising debt add pressure despite resilient core growth.